Amylyx Pharmaceuticals, Inc. Common Stock

AMLX US03237H1014

💰
Capitalization
Small-cap

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis. AMX0035 was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, as Relyvrio, in September 2022. It was withdrawn in April, 2024.

🏢
Founded
2013
🔗
Website
https://www.amylyx.com/
📚
Wikipedia
https://en.wikipedia.org/wiki/Amylyx_Pharmaceuticals
Annual Performance 1
2022 2023 2024 2025
104% -59% -75% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
45
🙍
Insiders
10
Person Price Shares Total Published Completed
Klee Justin B.
CEO 		14.37
USD 		29,775
Sold 		427,950
USD 		30/09/2025 30/09/2025
Mazzariello Gina
CLO 		14.58
USD 		8,828
Sold 		128,669
USD 		30/09/2025 30/09/2025
Cohen Joshua B
CEO 		15.00
USD 		200
Sold 		3,000
USD 		30/09/2025 30/09/2025
Frates James M
CFO 		14.65
USD 		10,558
Sold 		154,650
USD 		30/09/2025 30/09/2025
Klee Justin B.
CEO 		15.01
USD 		200
Sold 		3,002
USD 		30/09/2025 30/09/2025
Bedrosian Camille L
SR OFF 		14.58
USD 		12,039
Sold 		175,518
USD 		30/09/2025 30/09/2025
Cohen Joshua B
CEO 		14.34
USD 		29,733
Sold 		426,469
USD 		30/09/2025 30/09/2025
Mazzariello Gina
CLO 		8.34
USD 		15,000
Sold 		125,046
USD 		12/08/2025 13/08/2025
Mazzariello Gina
CLO 		8.07
USD 		15,000
Sold 		121,103
USD 		12/08/2025 12/08/2025
Cohen Joshua B
CEO 		3.47
USD 		21,490
Sold 		74,482
USD 		31/03/2025 31/03/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Amylyx Pharmaceuticals, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-1% 97% 14% -84% 0% 0% -78%
Last 52W Low 52W High All-Time Low All-Time High β
13.48 3.00 14.90 1.62 40.93
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Klee Justin B. 9 823,436.32 91,492.92 09/01/2024 30/09/2025
Cohen Joshua B 9 822,066.35 91,340.71 09/01/2024 30/09/2025
Mazzariello Gina 11 567,343.98 51,576.73 23/02/2024 30/09/2025
Frates James M 5 371,731.79 74,346.36 09/01/2024 30/09/2025
Bedrosian Camille L 4 285,167.10 71,291.77 30/09/2024 30/09/2025
Milne George M Jr 1 219,800.00 219,800.00 03/09/2024 03/09/2024
Firestone Karen 2 166,470.00 83,235.00 15/12/2023 05/09/2024
Yeramian Patrick D 1 45,914.62 45,914.62 09/01/2024 09/01/2024
Zeiher Bernhardt G 1 37,005.00 37,005.00 20/03/2025 20/03/2025
Quimi Daphne 2 9,436.02 4,718.01 14/05/2024 15/05/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.